Intervention of Dipyridamole and Acetylsalicylic Acid in the Deyelopment of Thrombosis in Cell-Mediated Immune Reactions: Possible Mechanism of Action

• References

• 1 Bailie Y, Jausseran J, Blanc T, Goudard A, Sicard M, Monties J, Henry E, Payan E, Lebreuil G, Sudan N, and Garbe G. 1972; Place de l’heparinotherapie dans la prevention du rejet apres transplantation cardiaque. Annales de Chirurgie Thoracique et Cardio-Vasculaire 11: 315.
• 2 Becker E, and Henson P. 1973; In vitro studies of immunologically induced secretion of mediators from cells and related phenomena. Advances in Immunology 17: 93.
• 3 Brown C, Turner D, Ogg C, Wilson D, Cameron J, and Chantler D. 1974; Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet 2: 1166.
• 4 Burnet M. F. 1959. The clonal selection of acquired immunity. Vanderbilt University Press; Nashville, Tennessee:
• 5 Coeugniet E. C, Bendtzen K, Soeberg B, and Bendixen G. 1975 Human leucocyte migration inhibitory activity and blastogenic activity of Con-A stimulated lymphocytes : modification by dipyridamole, lysine-acetylsalicylate and heparin. VI. Annual Meeting of the Scandinavian Society for Immunology, Bergen, Norway, 31.
• 6 Colvin R, and Dvorak H. 1975; Role of clotting system in cell-mediated hypersensitivity. Journal of Immunology 114: 377.
• 7 Fraser Mustard J, and Packham M. 1970; Factors influencing platelet function: adhesion, release and aggregation. Pharmacological Reviews 2: 97.
• 8 Kincaid Smith P. 1969; Modification of the vascular lesions of rejections in cadaveric renal allografts by dipyridamole and anticoagulants. Lancet 2: 920.
• 9 Mitchinson N. A. 1968. Recognition of antigen. In: Waren K. B. (ed.) Differentiation and Immunology. Academic Press; N.Y.: 29.